This Site is Compatible to Smart Phones & Tablet Computers.

BioRadious Therapeutics joins OVIS platform.

October 03rd 2018

 

OVIS is  the Indian national Cross Participation Platform for to obtain Clean Volunteers for BA BE studies has expanded its network in ndia.

 

Bioradius Therapeutics,  has joined the OVIS platform. Bioradius shall be operating its studies from Pune, India. 

OVIS offer Clean Volunteers for Risk Free studies based on the blood regeneration and drug washout parameters. The India wide Volunteers Eligibility Platform

OVIS has traced 1.3+ million In-eligible volunteers and has avoided Drug Reaction issues in them. Further OVIS has approved 2.5+ million volunteers for various studies across the country.

 

#OVIS #ClinicalResearch #CRO #LifeScience #ClinicalStudy #HumanVolunteers #CleanVolunteers #RiskFreeStudies #CrossParticipation #PhaseI #PhaseIII #EarlyStage #DrugTesting #ScreeningEligibility #DosingEligibility #RiskMitigation #HealthyVolunteers #LowCostStudies #SafeStudies #ADR #SADR #AvoidADR #DrugConcentration #RealTimeStatus #USFDA #CFR11 #BA #BE #PKStudies

 

Copyrights@2014.